{"id":"W1965294429","doi":"10.2174/187152607780090748","title":"Exploring DNA Topoisomerases as Targets of Novel Therapeutic Agents in the Treatment of Infectious Diseases","year":2007,"lang":"en","type":"review","venue":"Infectious Disorders - Drug Targets","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":82,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; Public Health Agency; National Institute of General Medical Sciences; National Institute of Allergy and Infectious Diseases; Institut pour la Recherche en Santé Publique; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Topoisomerase; DNA gyrase; Topoisomerase IV; Topoisomerase inhibitor; Biology; DNA; DNA supercoil; Gene; Biochemistry; DNA replication; Escherichia coli","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002085109,0.0006483925,0.001201456,0.0003390359,0.0001056423,0.00002378899,0.0003601001,0.0002360397,0.0000275773],"category_scores_gemma":[0.00003085552,0.000482621,0.0008761638,0.0004274313,0.0001412481,0.00001288852,0.00006372659,0.0001630057,0.000004814162],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001339451,"about_ca_system_score_gemma":0.0002487062,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008483004,"about_ca_topic_score_gemma":0.001192672,"domain_scores_codex":[0.99765,0.0001776719,0.0007936708,0.0005858154,0.000302652,0.0004901477],"domain_scores_gemma":[0.9984645,0.0001259344,0.0005527404,0.0006934775,0.0000773602,0.00008597573],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006695381,0.004611225,0.0005955349,0.001980022,0.001211765,0.000008174784,0.001053628,0.00008175293,0.000442954,0.0002894099,0.00005481251,0.9896038],"study_design_scores_gemma":[0.001712731,0.001503683,0.0001217436,0.0005924345,0.0007472713,0.0000240827,0.000175021,0.000004010569,0.002017123,0.0003457798,0.9921681,0.0005880024],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01607679,0.9806204,0.0003213996,0.00001885942,0.000734071,0.001466122,0.0001563402,0.00002505596,0.0005809953],"genre_scores_gemma":[0.1127776,0.8859789,0.00001020176,0.00011519,0.0001744348,0.0005317617,0.000264183,0.00008667147,0.00006104229],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9921133,"threshold_uncertainty_score":0.9997625,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07881365482780489,"score_gpt":0.3410781888377091,"score_spread":0.2622645340099042,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}